Urinary soluble VCAM-1 in systemic lupus erythematosus: A clinical marker for monitoring disease activity and damage

Clinical and Experimental Rheumatology

Volumn 20, Issue 3, 2002, Pages 403-406

  Molad, Yair ^a   Miroshnik, Eugen ^a   Sulkes, Jaqueline ^a   Pitlik, Silvio ^a   Weinberger, Abraham ^a   Monselise, Yehudit ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Disease activity; ICAM 1; Lupus; Nephritis; VCAM 1

Indexed keywords

COMPLEMENT COMPONENT C3; CREATININE; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE CLEARANCE; DATA ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATURIA; HUMAN; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; OUTCOMES RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; PROTEINURIA; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS; URINE LEVEL;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0036559142     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. The adhesion molecules of inflammation
2. Leukocyte adhesion molecules and kidney diseases
3. Upregulation and co-localization of connexin 43 and cellular adhesion molecules in inflammatory renal disease
4. Intercellular adhesion molecule-1 expression in human kidneys with glomerulonephritis
5. Expression of VCAM-1 in the normal and diseased kidney
6. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis
7. Vascular cell adhesion molecule-1 (VCAM- 1) expression in murine lupus nephritis
8. Requirements for leukocyte adhesion molecules in nephrotoxic nephritis
9. Circulating adhesion molecules in disease
10. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic ]opus erythematous (SLE): A long term prospective study
11. Upregulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematous. The Shwartzman phenomenon revisited
12. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis
13. Measurement of soluble ICAM-1 after renal transplantation
14. Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients
15. Lupus nephritis
16. Lupus nephropathy without clinical renal involvement
17. The 1982 revised criteria for the classification of systemic lupus erythematous
18. The development and validation of the SLE Disease Activity Index (SLEDAI)
19. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus
20. VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematous is increased compared with systemic and localized scleroderma
21. Upregulation of adhesion molecule expression on endothelial cells by anti-DNA auto antibodies in systemic lupus erythematous
22. Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis
23. Distinct patterns of expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease
24. Gomerular ICAM-1 expression related to circulating TNF-α in human glomerulonephritis
25. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematous and chronic renal failure
26. Relationship between lupus nephritis activity and serum levels of soluble VCAM-1